Stryker’s OP-1 Putty on PMA track
This article was originally published in The Gray Sheet
Executive Summary
Firm submits PMA for OP-1 Putty bone morphogenetic protein for posterior lateral spinal fusion, the firm announces June 26. The device has been available in the U.S. on a limited basis under a humanitarian device exemption granted in April 2004. Following lackluster hip and knee sales in late 2005, Stryker has cited the BMP product as a potential future growth driver...